CDB-2914 for Uterine Leiomyomata Treatment: A Randomized Controlled Trial

2008

OBJECTIVE To evaluate whether 3-month administration of CDB-2914, a selective progesterone receptor modulator, reduces leiomyoma size and symptoms.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

18

References

146

Citations